Neion Bio uses genetically engineered chickens to produce therapeutic proteins in eggs, aiming for a drastic reduction in the ...
Researchers at Hannover Medical School (MHH) have developed a method for the efficient production of human immune cells, such as macrophages, in medium-sized bioreactors. These immune cells can be ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer. Sources close to the deal confirmed to TechCrunch ...
A new laboratory protocol could make it far easier to generate one of the immune system’s most versatile cell types. Scientists led by Nico Lachmann, PhD, at Hannover Medical School have developed a ...
There are hundreds of biotechnology companies today that have never commercialized a drug. For many years, the standard approach in the industry has been to advance the science, prove the asset, and ...
Whisper it, but we may finally be seeing the IPO window reopening in 2026. Biotech listings saw their heyday in the middle of the COVID-19 pandemic, when an incredible 87 U.S.-based drug developers ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Research Scientist in Lab For years, public debate around U.S. dependence on China has ...